The meta-analysis was performed by means of Review Manager 5.3 (Cochrane Collaboration, Oxford, UK). As for dichotomous variables, the ORs were calculated, reporting 95% CI. Survival outcomes were summarized by using the generic inverse variance method. Overall survival (OS) was defined as the time from diagnosis until death. Disease-free survival (DFS) was defined as the interval between the initial primary diagnosis of CRC and the first relapse or death. Hazard ratio (HR) and 95% CI were calculated to assess the association between high level of F. nucleatum and survival. A fixed model was performed in aggregating and analyzing for results when I2< 50%. If I2 >50%, the random-effects analysis was utilized. The pooled effects were determined by conducting a Z test, and the statistical significance was defined as the two-sided P < 0.05.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.